Table 3 Laboratory tests after aspirin treatment
From: Effect of different doses of aspirin on the prognosis of Kawasaki disease
Group | 1 | 2 | 3 | P-value |
|---|---|---|---|---|
N | 510 | 1487 | 372 | |
WBC2(10^9/L) | 8.37 ± 3.39 | 8.67 ± 3.36 | 8.94 ± 3.90 | 0.065 |
HB2(g/L) | 109.80 ± 11.34 | 108.46 ± 10.55 | 106.32 ± 10.71 | <0.001 |
PLT2(10^9/L) | 522.29 ± 173.58 | 544.69 ± 172.46 | 557.77 ± 193.50 | 0.013 |
ANC2(10^9/L) | 2.44 (1.68–3.93) | 2.60 (1.66–3.93) | 2.45 (1.56–3.76) | 0.416 |
CRP2(mg/L) | 7.76 (3.00–14.42) | 8.00 (3.83–15.18) | 7.01 (3.00–14.28) | 0.028 |
ESR2(mm/h) | 35.57 ± 19.49 | 35.82 ± 19.64 | 32.48 ± 16.86 | 0.439 |
ALT2(u/L) | 27.00 (18.00–43.00) | 28.00 (19.00–44.00) | 27.00 (18.00–46.75) | 0.606 |
AST2(u/L) | 42.00 (35.00–55.00) | 42.00 (35.00–55.00) | 43.00 (35.00–61.00) | 0.456 |
Albumin2(g/L) | 36.01 ± 4.30 | 35.40 ± 4.74 | 34.40 ± 4.55 | < 0.001 |
PT2(s) | 12.82 ± 0.91 | 12.81 ± 0.78 | 12.81 ± 0.69 | 0.978 |
APTT2(s) | 39.51 ± 6.13 | 39.69 ± 5.67 | 38.92 ± 5.26 | 0.251 |
FIB2(g/L) | 4.19 ± 0.92 | 4.09 ± 0.94 | 3.86 ± 1.00 | < 0.001 |
TT2(s) | 17.38 ± 1.41 | 17.41 ± 1.17 | 17.34 ± 1.24 | 0.780 |
D-Dimers2 (ug/ml) | 0.98 (0.71–1.49) | 0.92 (0.68–1.42) | 0.88 (0.62–1.47) | 0.198 |